Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Puma Biotechnology (PBYI) Return on Equity (2017 - 2025)

Puma Biotechnology (PBYI) has disclosed Return on Equity for 9 consecutive years, with 0.29% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Return on Equity changed 0.0% year-over-year to 0.29%, compared with a TTM value of 0.29% through Dec 2025, changed 0.0%, and an annual FY2024 reading of 0.33%, up 36.0% over the prior year.
  • Return on Equity was 0.29% for Q4 2025 at Puma Biotechnology, up from 0.28% in the prior quarter.
  • Across five years, Return on Equity topped out at 4.36% in Q4 2021 and bottomed at 20.86% in Q1 2022.
  • Average Return on Equity over 5 years is 1.17%, with a median of 0.28% recorded in 2025.
  • The sharpest move saw Return on Equity tumbled -1879bps in 2022, then soared 2161bps in 2023.
  • Year by year, Return on Equity stood at 4.36% in 2021, then plummeted by -86bps to 0.59% in 2022, then crashed by -104bps to 0.02% in 2023, then skyrocketed by 1325bps to 0.29% in 2024, then decreased by 0bps to 0.29% in 2025.
  • Business Quant data shows Return on Equity for PBYI at 0.29% in Q4 2025, 0.28% in Q3 2025, and 0.42% in Q2 2025.